Diabetes and weight loss drug could also help sleep apnoea

Embargoed until: Publicly released: 2024-06-21 16:30

Australia; International; NSW

Image by JayMantri from Pixabay

Diabetes and weight loss drug tirzepatide, sold under the name Mounjaro, could also help treat sleep apnoea, according to Australian and international research. A year of treatment with the drug, which works in a similar way to Ozempic, was found to reduce sleep apnoea symptoms, increase weight loss, and improve sleep in people with moderate-to-severe obstructive sleep apnoea compared to placebo.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: NEJM

Research:Paper

Organisation/s: Macquarie University, The University of Sydney, University of California, USA

Funder: Funded by Eli Lilly

Media Contact/s

Contact details are only visible to registered journalists.